InvestorsHub Logo
icon url

XenaLives

07/26/17 10:36 AM

#212657 RE: apljack #212655

TTPH is totally controlled by algos, so this morning's action is not surprising. Given yesterdays trial results, how long do you think it will be before the FDA approves Eceracycline?
icon url

tika1

07/26/17 10:54 AM

#212658 RE: apljack #212655

TTPH

I read somewhere potential revenue of Eravacycline is $700M. I was expecting better market reaction than just 10%. Hopefully slowly price will appreciate.


Stifel Nicolaus upgraded to Buy with a $15 price target. Other analyst will follow soon imo.
icon url

DewDiligence

07/26/17 4:55 PM

#212678 RE: apljack #212655

TTPH selling $69M of stock on unspecified terms:

https://globenewswire.com/news-release/2017/07/26/1063075/0/en/Tetraphase-Announces-Proposed-Public-Offering-of-Common-Stock.html

*Assuming exercise of underwriter’s option.